neurofibromotosis glutathione Neurofibromatosis type I Metabolic Features of Neurofibromatosis Type

At the start, lifestyle advice was given

[179] and Demers et al

The deliberations spanned epidemiology, clinical presentation, diagnosis including autoantibodies, immunoglobulin G (IgG), histology and diagnostic scores, therapeutic strategies, management of difficult-to-treat AIH, long-term monitoring, and special scenarios, such as seronegative AIH (SN-AIH), autoimmune sclerosing cholangitis/overlap syndromes and post-transplant complications like recurrence and de novo-AIH

10.4161/gmic.25487 Gut Microbes 53 GuenicheA.BenyacoubJ.PhilippeD.BastienP.KusyN.BretonL.et al (2010)

doi:10.1177/1535370218758275 Iftikhar A, Azam H, Ahmed M, et al